{"id":"CHEMBL112302","canonicalSmiles":"O=[Se]([O-])[O-].[Na+].[Na+]","inchiKey":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SELENITE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2009089","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disodium selenite","NSC-347466","Selenious acid disodium salt","Selenious acid, disodium salt","Sodium Selenite","Sodium selenite","Sodium selenite anhydrous"],"crossReferences":{"DrugCentral":["4782"],"PubChem":["144210175"],"Wikipedia":["Sodium_selenite"],"chEBI":["48843"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1161861","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1OP(=O)(O)O","inchiKey":"AEOBEOJCBAYXBA-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Adenosine 2',5'-Diphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine 2',5'-Diphosphate"],"crossReferences":{"drugbank":["DB02098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116597","canonicalSmiles":"N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1","inchiKey":"MEPJWLFTTFHOQO-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL116597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07143"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173328","canonicalSmiles":"Cc1cccc(O)c1O","inchiKey":"PGSWEKYNAOWQDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Methylcatechol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methylcatechol"],"crossReferences":{"drugbank":["DB03454"],"chEBI":["18404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL119385","canonicalSmiles":"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl","inchiKey":"VEPKQEUBKLEPRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEFLAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["745","Neflamapimod","VD-31","VD-31,745","VD-31745","VRT-031745","VX-745","Vx-745"],"crossReferences":{"PubChem":["103905630","124950172","174006470","50100122"],"drugbank":["DB07138"],"chEBI":["90528"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","HP_0100543","HP_0000726","MONDO_0004975"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200400","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[n-]c12.[Na+]","inchiKey":"WISNYKIQFMKSDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AZATHIOPRINE SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1542","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azathioprine sodium","Imuran"],"synonyms":["Azathioprine sodium","Azathioprine sodium salt"],"crossReferences":{"DailyMed":["azathioprine%20sodium"]},"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000384"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200558","canonicalSmiles":"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1","inchiKey":"CLKOFPXJLQSYAH-ABRJDSQDSA-N","drugType":"Protein","blackBoxWarning":true,"name":"BACITRACIN","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albac 50","Baci-rx","Baciferm 50","Baciguent","Baciim","Bacitracin"],"synonyms":["Bacilliquin","Bacitracin","Bacitracin(non-injectable)","Bacitracin, sterile","Bacitracinum","E700","Fortracin","NSC-755905","Parentracin","Penitracin","Topitracin","Tropitracin","Zutracin"],"crossReferences":{"DailyMed":["bacitracin","bacitracin%20zinc"],"DrugCentral":["281"],"Wikipedia":["Bacitracin"],"drugbank":["DB00626"],"chEBI":["35862"]},"childChemblIds":["CHEMBL2096639"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 5 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200727","canonicalSmiles":"[82Rb+].[Cl-]","inchiKey":"FGDZQCVHDSGLHJ-RYDPDVNUSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"RUBIDIUM CHLORIDE RB 82","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110557","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardiogen","Cardiogen-82","Ruby-fill"],"synonyms":["82rbcl","Rubidium (82 rb) chloride","Rubidium (82rb) chloride","Rubidium chloride ((sup 82)rbcl)","Rubidium chloride rb 82","Rubidium chloride rb-82","Rubidium rb-82 chloride"],"crossReferences":{"DailyMed":["rubidium%20chloride%20rb-82"],"DrugCentral":["5184"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for coronary artery disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200758","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"KLOHDWPABZXLGI-YWUHCJSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPICILLIN SODIUM","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL174","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amp Equine","Ampicillin sodium","Omnipen","Omnipen-n","Penbritin","Penbritin-s","Polycillin","Polycillin-n","Principen","Principen-N","Totacillin","Totacillin-n"],"synonyms":["Ampicillin (as sodium)","Ampicillin sodium","Ampicillin sodium salt","Ampicillin sodium, sterile","Ampicillinum natricum","NSC-755864"],"crossReferences":{"DailyMed":["ampicillin%20sodium"],"PubChem":["11533065"],"chEBI":["34535"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1200848","canonicalSmiles":"CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DOMWKUIIPQCAJU-LJHIYBGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYPROGESTERONE CAPROATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delalutin","Hydroxyprogesterone caproate","Makena","Makena (autoinjector)","Makena preservative free","Proluton depot"],"synonyms":["17-ohpc","17.alpha.-caproyloxy-p4","Depo-proluton","Hormofort","Hydroxyprogesterone","Hydroxyprogesterone caproate","Hydroxyprogesterone hexanoate","Hylutin","NSC-17592","Oxiprogesterone caproate","Pharlon","Primolut depot","Procyte depo","Proge","Syngynon","Teralutil"],"crossReferences":{"DailyMed":["hydroxyprogesterone%20caproate"],"PubChem":["144207051","144212650","170465210","56424128","855528"],"drugbank":["DB06789"],"chEBI":["5812"]},"childChemblIds":["CHEMBL3526451"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MONDO_0012511","EFO_0003917","EFO_0000668","EFO_0003922","EFO_0002950"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for premature birth and has 1 investigational indication."}
{"id":"CHEMBL1200850","canonicalSmiles":"Nc1nc([O-])c2ncn(COC(CO)CO)c2n1.[Na+]","inchiKey":"JJICLMJFIKGAAU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"GANCICLOVIR SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL182","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytovene","Ganciclovir","Ganciclovir sodium"],"synonyms":["Cytovene iv","Ganciclovir (as sodium)","Ganciclovir sodium","Ganciclovir sodium salt","RS-21592 SODIUM"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200966","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.[Na+]","inchiKey":"FVVDKUPCWXUVNP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM AMINOSALICYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminosalicylate sodium","Sodium Aminosalicylate","Sodium aminosalicylate"],"crossReferences":{"PubChem":["11532911","170465206","26747852"],"chEBI":["2661"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201000","canonicalSmiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)[N-]1.[Na+]","inchiKey":"AFDJQFFKYDCYIG-JSGFVSQVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROFURANTOIN SODIUM","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL572","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ivadantin"],"synonyms":["Nitrofurantoin sodium","Sodium nitrofurantoin"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201051","canonicalSmiles":"CN/C(=N\\CCSCc1nc[nH]c1C)NC#N.Cl","inchiKey":"QJHCNBWLPSXHBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETIDINE HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL30","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cimetidine hydrochloride","Tagamet"],"synonyms":["Cimetidine hcl","Cimetidine hydrochloride"],"crossReferences":{"chEBI":["50362"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201245","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1","inchiKey":"NUNIWXHYABYXKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMODIPHENHYDRAMINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4-bromodiphen hydramine","Bromazine","Bromodiphenhydramine","Deserol","Histabromamine","Neo-benadryl"],"crossReferences":{"PubChem":["170465292"],"Wikipedia":["Bromazine"],"drugbank":["DB01237"],"chEBI":["59177"]},"childChemblIds":["CHEMBL1200967"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and is indicated for allergic disease."}
{"id":"CHEMBL1201421","drugType":"Unknown","blackBoxWarning":false,"name":"PEGAPTANIB SODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macugen"],"synonyms":["EYE-001","EYE001","EYEOO1","NX-1838","NX1838","Pegaptanib na","Pegaptanib sodium"],"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","Orphanet_892","MONDO_0003005","EFO_0004683","EFO_0001365","EFO_1001157","EFO_0005753","EFO_0009322","EFO_0009321"],"count":9},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for ocular vascular disease and wet macular degeneration and has 5 investigational indications."}
{"id":"CHEMBL1201775","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1.Cl.Cl","inchiKey":"RKSUYBCOVNCALL-NTVURLEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPROPTERIN DIHYDROCHLORIDE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201774","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kuvan"],"synonyms":["Biopten","Dapropterin hydrochloride","Phenoptin","SUN-0588","SUN-0588 (SHIRATORI)","Sapropterin dihydrochloride","Sapropterin hydrochloride","T-1401","T1401","T1401 (BIOMARIN)"],"crossReferences":{"DailyMed":["sapropterin%20dihydrochloride"],"PubChem":["144205335"],"chEBI":["32120"]},"linkedTargets":{"rows":["ENSG00000171759"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0001361","Orphanet_716","Orphanet_232","Orphanet_238583","EFO_0003884","EFO_0001645","EFO_0003758","EFO_1001461","EFO_0003876","EFO_0005411","EFO_0004265","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for phenylketonuria and hyperphenylalaninemia and has 8 investigational indications."}
{"id":"CHEMBL1201865","drugType":"Enzyme","blackBoxWarning":false,"name":"VELAGLUCERASE ALFA","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vpriv"],"synonyms":["EC 3.2.1.45","EC-3.2.1.45","Ga-gcb","Velaglucerase alfa"],"crossReferences":{"DailyMed":["velaglucerase%20alfa"],"DrugCentral":["4989"],"Wikipedia":["Velaglucerase_alfa"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2010 and is indicated for gaucher disease."}
{"id":"CHEMBL122264","canonicalSmiles":"c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1","inchiKey":"XWWRLKIBRPJQJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6094","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6094"],"crossReferences":{"drugbank":["DB06948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232589","canonicalSmiles":"CCNC","inchiKey":"LIWAQLJGPBVORC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLETHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235132","canonicalSmiles":"NC(=O)c1cccc([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)n1","inchiKey":"LFERELMXERXKKQ-KMXXXSRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235810","canonicalSmiles":"Cc1nc2cc3nc(N)[nH]c(=O)c3cc2[nH]1","inchiKey":"PLJNUNPYZVVIRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235810","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1252","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"AIWRTTMUVOZGPW-HSPKUQOVSA-N","drugType":"Protein","blackBoxWarning":true,"name":"ABARELIX","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Plenaxis"],"synonyms":["Abarelix","PPI-149","Plenaxis","R-382","R-3827","R382","R3827"],"crossReferences":{"Wikipedia":["Abarelix"],"drugbank":["DB00106"],"chEBI":["337298"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008315"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for neoplasm and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL126","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1","inchiKey":"TYZROVQLWOKYKF-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINEZOLID","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Linezolid","Zyvox"],"synonyms":["Linezolid","Pnu-100766","U-100,766","U-100766","Zyvox"],"crossReferences":{"DailyMed":["linezolid"],"PubChem":["144205799","26719842","49681612"],"Wikipedia":["Linezolid"],"drugbank":["DB00601"],"chEBI":["63607"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL127300","canonicalSmiles":"COc1cc(C(=O)OCCCN(C)CCN(C)CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC","inchiKey":"KRQAMFQCSAJCRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOBENDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexobendine"],"crossReferences":{"drugbank":["DB13265"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1372950","canonicalSmiles":"CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13","inchiKey":"YSEXMKHXIOCEJA-FVFQAYNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICERGOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sermion"],"synonyms":["Cergodum","Circo-maren","Dilasenil","Duracebrol","Ergobel","Ergotop","FI-6714","Memoq","NSC-150531","Nicergolent","Nicergoline","Nilogrin","Vasospan"],"crossReferences":{"PubChem":["104171344","124882915","144204361","170465878","26751796","50104491"],"drugbank":["DB00699"],"chEBI":["31902"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL1466172","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccccc1","inchiKey":"CUUCCLJJOWSASK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRONIDAZOLE BENZOATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoyl metronidazole","Klion suspension","Metronidazole benzoate","Metronidazoli benzoas"],"crossReferences":{"PubChem":["17504163"],"chEBI":["50688"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1502","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC","inchiKey":"IQPSEEYGBUAQFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOPRAZOLE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pantoloc control","Protium","Protium i.v."],"synonyms":["Altopan","BY 1023","BY-1023","NSC-759257","Pantocid","Pantoloc","Pantoprazole","Pantozol","Protonix","SK&F 96022","SK&F-96022","SK-96022","SKF-96022","Zovanta"],"crossReferences":{"DailyMed":["pantoprazole%20sodium"],"PubChem":["144205030","170466337","174007264","26749082"],"Wikipedia":["Pantoprazole"],"drugbank":["DB00213"],"chEBI":["7915"]},"childChemblIds":["CHEMBL3989559","CHEMBL1200408"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0002239","EFO_0000373","MONDO_0043839","EFO_0003948","HP_0004398","EFO_0000771","EFO_0000337","EFO_0003931","EFO_0007157","EFO_1000961","EFO_0000400","EFO_0000616","EFO_0000280","EFO_0001645","HP_0002012","EFO_0005407","EFO_0007549","EFO_0003843","MONDO_0008315","MONDO_0003523","EFO_1001355","EFO_0008533","EFO_0009454","MP_0001914","Orphanet_79292","MONDO_0005301","MONDO_0005147","MONDO_0005148","HP_0100633","EFO_0005672","EFO_0009544","EFO_0009878"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 22 investigational indications."}
{"id":"CHEMBL1523964","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O","inchiKey":"CAVQBDOACNULDN-KHFUBBAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE SULFATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL211456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akovaz","Corphedra","Emerphed","Expansyl","Franol plus","Franol-plus","Isofedrol"],"synonyms":["Ephedrine sulfate","Ephedrine sulphate","Ephedrini sulfas"],"crossReferences":{"DailyMed":["ephedrine%20sulfate"],"PubChem":["50106282"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["MONDO_0004979","HP_0001742","EFO_0007214","EFO_0003956","EFO_0005251"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 5 approved indications."}
{"id":"CHEMBL1625607","canonicalSmiles":"CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1","inchiKey":"FQQIIPAOSKSOJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBHYDROLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fabahistin","Incidal","Omeril"],"synonyms":["Bexidal","Mebhydrolin","Mebhydrolin napadisilate","Mebhydrolin napadisylate","NSC-757830"],"crossReferences":{"drugbank":["DB13808"]},"childChemblIds":["CHEMBL1714118","CHEMBL1324326","CHEMBL1600878","CHEMBL1394472"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergic disease."}
{"id":"CHEMBL1631540","canonicalSmiles":"Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1","inchiKey":"ANGUXJDGJCHGOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK163090","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK163090","Gsk163090"],"childChemblIds":["CHEMBL3215829"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000108576","ENSG00000135312","ENSG00000179546"],"count":4},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1673408","canonicalSmiles":"CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1","inchiKey":"QLUWQAFDTNAYPN-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELPAZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delpazolid","LCB-01-0371","LCB-010371","Lcb01-0371"],"crossReferences":{"drugbank":["DB13077"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL172155","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1","inchiKey":"POQDXIFVWVZVML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL172155","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09182"]},"childChemblIds":["CHEMBL2361433"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1730601","canonicalSmiles":"Oc1cc(O)c(Cl)cn1","inchiKey":"ZPLQIPFOCGIIHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIMERACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gimeracil","Gimestat"],"crossReferences":{"PubChem":["144206214","170466048","50125750"],"drugbank":["DB09257"]},"linkedTargets":{"rows":["ENSG00000188641"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0000365","EFO_1000657","MONDO_0007254","EFO_0004252","EFO_0000228","MONDO_0044937","EFO_1001951","MONDO_0001056","EFO_0000178","EFO_1001480","EFO_1000218","EFO_1000044","EFO_0003860","MONDO_0002974","EFO_0009812","EFO_0000182","EFO_0002618","EFO_0003897","EFO_0000616","EFO_0006859","EFO_0005922","EFO_0002916","EFO_0000503","EFO_0005842","MONDO_0007576","EFO_0003060","EFO_0005221","EFO_0000311","MONDO_0002120","EFO_0002517","EFO_0000702","EFO_0004142","MONDO_0003219","EFO_0000181"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 32 investigational indications."}
{"id":"CHEMBL1743015","drugType":"Antibody","blackBoxWarning":false,"name":"ETROLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-.beta.7","Anti-Beta7","Anti-Beta7 Pro145223","Etrolizumab","PRO-145223","PRO145223","RG-7413","RHUMAB-BETA7","Rhumab .beta.7","rhuMAb beta7"],"linkedTargets":{"rows":["ENSG00000139626"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1851943","canonicalSmiles":"CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC","inchiKey":"JHDKZFFAIZKUCU-ZRDIBKRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRACINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pracinostat","SB 939","SB-939","Sb939"],"crossReferences":{"drugbank":["DB05223"]},"childChemblIds":["CHEMBL3215861"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL185586","canonicalSmiles":"C[C@@](O)(CBr)CCOP(=O)(O)OP(=O)(O)O","inchiKey":"YKAYCWPQDPILSA-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL187927","canonicalSmiles":"c1cnc2c(c1)O[C@H]1CCN3CC[C@@]1(C2)C3","inchiKey":"SUPRUPHAEXPGPF-QWHCGFSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIANICLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dianicline","SSR-591813","SSR591813"],"crossReferences":{"drugbank":["DB12125"]},"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003768"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1885178","canonicalSmiles":"C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1","inchiKey":"XMSXQFUHVRWGNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1885178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213487","26757398"],"drugbank":["DB11244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1889140","canonicalSmiles":"CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"NDNSIBYYUOEUSV-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1077896","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Narapin","Naropin","Ropivacaine hydrochloride"],"synonyms":["Ropivacaine hcl","Ropivacaine hydrochloride","Ropivacaine hydrochloride hydrate","Ropivacaine hydrochloride monohydrate"],"crossReferences":{"DailyMed":["ropivacaine%20hydrochloride"],"PubChem":["144205774","170465120","49681555"],"chEBI":["60803"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0006859","EFO_0003931","HP_0030839","HP_0001385","MONDO_0007254","HP_0001822","EFO_0003843","MONDO_0005178","EFO_0008553","HP_0000023"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for pain and has 4 investigational indications."}
{"id":"CHEMBL190279","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C","inchiKey":"DUHUCHOQIDJXAT-OLVMNOGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFAXALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alfaxalone","Alphaxalone","GR 2/234","Phaxan"],"crossReferences":{"PubChem":["144204435","170466428","50104098","50104100","56422127","855840","90341788"],"Wikipedia":["Alfaxalone"],"drugbank":["DB11371"],"chEBI":["34531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1911882","canonicalSmiles":"CN(CCCNCc1ccc2c(c1)OCO2)c1nc(-n2ccnc2)ns1","inchiKey":"ZJFFPGMGWOEQLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KD7040","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kd7040"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2096635","canonicalSmiles":"N[14C](N)=O","inchiKey":"XSQUKJJJFZCRTK-NJFSPNSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA C 14","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pytest","Pytest kit"],"synonyms":["14c-urea","Carbon 14 urea","Carbon-14 urea","Urea ((sup 14)c)","Urea (14c)","Urea 14 c","Urea c 14","Urea c-14","Urea, c-14","Urea-14c"],"crossReferences":{"DailyMed":["urea,%20c-14"],"drugbank":["DB09513"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for infection."}
{"id":"CHEMBL2104282","canonicalSmiles":"CCN(CC)CCn1c(-c2ccccc2)noc1=N","inchiKey":"MGSPDRWOUCPKNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imolamine"],"crossReferences":{"drugbank":["DB09284"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105534","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2cn3ccccc3n2)cc1","inchiKey":"VSLIUWLPFRVCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLIMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Solimidin","Zolimidine","Zoliridine"],"crossReferences":{"PubChem":["170466528"],"drugbank":["DB13593"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105705","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"RFQHCLMGLJGZNV-UXXOMSPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUNACALCIPOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTA-018","CTA018","Lunacalcipol"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003884","EFO_0000676","EFO_0009909"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106186","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(c1ccccc1)NC2=O","inchiKey":"DBDTUXMDTSTPQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENQUIZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Idrolone"],"synonyms":["Fenquizone","M.G. 13054","MG-13054"],"crossReferences":{"drugbank":["DB13708"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106317","canonicalSmiles":"Nc1c(I)cc(I)c(C(=O)N(CCC(=O)O)c2ccccc2)c1I","inchiKey":"FJYJNLIEGUTPIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENZAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Osbil"],"synonyms":["Iobenzamic acid"],"crossReferences":{"PubChem":["170465948"],"drugbank":["DB13428"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108296","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AGANIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aganirsen","Gs-101"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108327","drugType":"Protein","blackBoxWarning":false,"name":"LANCOVUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Duramycin","Lancovutide","Leucopeptin","MOLI-1901","MOLI1901","Moli1901"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108674","drugType":"Protein","blackBoxWarning":false,"name":"RAMATERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ace-031"],"synonyms":["ACE-031","Ramatercept"],"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","EFO_0002970"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108952","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN SULFATE SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran sulfate sodium"],"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109314","drugType":"Antibody","blackBoxWarning":false,"name":"GS-CDA1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-CDA1","Gs-cda1"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109391","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-447","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-82633","MDX-447","Mdx-447"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000150337"],"count":2},"linkedDiseases":{"rows":["EFO_1000158"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109446","drugType":"Antibody","blackBoxWarning":false,"name":"KD-247","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KD-247","Kd-247"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109530","drugType":"Antibody","blackBoxWarning":false,"name":"ASK-8007","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASK-8007","Ask-8007"],"linkedTargets":{"rows":["ENSG00000118785"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109559","drugType":"Antibody","blackBoxWarning":false,"name":"J591 177LU","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["177 LU-J591","HUJ591-GS","J591 177lu"],"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL217092","canonicalSmiles":"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1","inchiKey":"OUKYUETWWIPKQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARACATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-10353926","AZD-0530","AZD0530","Azd-0530","Saracatinib"],"crossReferences":{"PubChem":["137275842","164339484"],"drugbank":["DB11805"]},"childChemblIds":["CHEMBL2105677"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000197122"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000637","EFO_0000365","EFO_0004329","MONDO_0015686","EFO_0000756","MONDO_0008170","EFO_1000657","MONDO_0007254","MONDO_0021063","Orphanet_538","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0002158","EFO_1000581","EFO_1000044","EFO_0006861","MONDO_0004975","MONDO_0007079","Orphanet_337"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL217894","canonicalSmiles":"CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O","inchiKey":"VMEGFMNVSYVVOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECYLUBIQUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decylubiquinone"],"crossReferences":{"PubChem":["26756779","26756780"],"drugbank":["DB07640"],"chEBI":["52020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2179529","canonicalSmiles":"O=C(c1ccc(Cl)o1)N1CC2CNCC2C1","inchiKey":"GTUIQNHJSXQMKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1446","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-1446","AZD1446 HCL","Azd 1446","Azd1446","Azd1446 free base","TC-6683","TC6683","TC6683 HCL"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220050","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)C1=O","inchiKey":"ACEFOQMQINFMRW-DYCFVMESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW813893","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW813893","Gw813893"],"crossReferences":{"drugbank":["DB07278"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL220360","canonicalSmiles":"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1","inchiKey":"QLYKJCMUNUWAGO-GAJHUEQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARANABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0364","MK-0634","Mk-0364","Mk0364","Taranabant"],"crossReferences":{"drugbank":["DB06624"]},"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["HP_0000020","EFO_0003768","EFO_0001073","MONDO_0005148"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL226403","canonicalSmiles":"O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21","inchiKey":"OWFLADWRSCINST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905260"],"drugbank":["DB08358"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227744","canonicalSmiles":"N=C(NCCC[C@H](N)C(=O)O)N[N+](=O)[O-]","inchiKey":"MRAUNPAHJZDYCK-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N (g)-NITRO-L-ARGININE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-N-Nitroarginine","L-Nitroarginine","L-Nw-Nitroarginine"],"crossReferences":{"PubChem":["11113630","50104528","50104529","50104530","90341713"],"drugbank":["DB04223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2356648","canonicalSmiles":"Cl.Cl.Cl.N=C(N)NCCCCCCC(=O)NC(O)C(=O)NCCCCNCCCN","inchiKey":"AXSPHUWXYSZPBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUSPERIMUS TRIHYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL406117","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["15-deoxyspergualin trihydrochloride","BMS-181173","BMY-42215-1","Gusperimus hydrochloride","Gusperimus trihydrochloride","NKT-01","NSC-356894","Spanidin"],"crossReferences":{"PubChem":["144206777"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL239507","canonicalSmiles":"CNCc1cc(=O)oc2cc(OCc3cccc(Cl)c3)ccc12","inchiKey":"JMGUSOLCNQVZCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239507","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07513"]},"childChemblIds":["CHEMBL593763"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253371","canonicalSmiles":"CCN(CCCc1ccccc1)CCCc1ccccc1","inchiKey":"ZPFXAOWNKLFJDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alverine","Phenpropamine"],"crossReferences":{"PubChem":["50103849","50104229","50104230"],"Wikipedia":["Alverine"],"drugbank":["DB01616"],"chEBI":["518413"]},"childChemblIds":["CHEMBL1408594"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000101076"],"count":2},"linkedDiseases":{"rows":["EFO_0010282","EFO_0000555"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL254219","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O","inchiKey":"WDJUZGPOPHTGOT-XUDUSOBPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGITOXIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crystodigin","Digimerck","Nativelle digitaline"],"synonyms":["CRYSTODIGIN","Cristapurat","Digitalin, crystalline","Digitophyllin","Digitoxin","Digitoxinum","Digitoxoside","Glucodigin","Lanatoxin","NSC-7529","Purpurid","Tradigal"],"crossReferences":{"PubChem":["11533060","144205212","144212586","170464713","26754428","26754429"],"Wikipedia":["Digitoxin"],"drugbank":["DB01396"],"chEBI":["28544"]},"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["Orphanet_586","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL254468","canonicalSmiles":"N[C@]1(C(=O)O)C[C@@H]([18F])C1","inchiKey":"NTEDWGYJNHZKQW-DGMDOPGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL254468","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1908917","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13146"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260585","canonicalSmiles":"Oc1cc(Cc2ccccn2)ccc1Oc1ccc(Cl)cc1Cl","inchiKey":"AOVDSWPGWPRTSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL260585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07287"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26717","canonicalSmiles":"NS(=O)(=O)c1ccc2c(c1)CNCC2","inchiKey":"UGLLZXSYRBMNOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SK&F-29661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SK&F-29661","SK-29661"],"crossReferences":{"drugbank":["DB03468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282093","canonicalSmiles":"NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1","inchiKey":"NSQNZEUFHPTJME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-58236","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-58236"],"crossReferences":{"drugbank":["DB14059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298826","canonicalSmiles":"Clc1ccc([C@H]2C[C@@H]3CC[C@H]2N3)cn1","inchiKey":"NLPRAJRHRHZCQQ-IVZWLZJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-EPIBATIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epibatidine"],"crossReferences":{"Wikipedia":["Epibatidine"],"drugbank":["DB07720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298827","canonicalSmiles":"O=C(O)CNC(=O)[C@@H](CS)Cc1ccccc1","inchiKey":"LJJKNPQAGWVLDQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-THIORPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111898","11112848"],"drugbank":["DB08626"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301327","canonicalSmiles":"COc1ccc2c(c1)OC(C)(C)[C@@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1","inchiKey":"XZEUAXYWNKYKPL-WDYNHAJCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVORMELOXIFENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-centchroman","Centchroman (-)-form","L-centchroman","Levormeloxifene"],"crossReferences":{"PubChem":["144206269"],"Wikipedia":["Levormeloxifene","Ormeloxifene"],"drugbank":["DB13310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039558","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIRINOTECAN PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etirinotecan pegol","NKTR-102"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170","MONDO_0007254","EFO_0002499","EFO_0002501","EFO_0000519","EFO_0003060","EFO_0000311","EFO_1001951"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3039566","drugType":"Unknown","blackBoxWarning":false,"name":"SUCROFERRIC OXYHYDROXIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velphoro"],"synonyms":["PA21","Sucroferric oxyhydroxide"],"crossReferences":{"DrugCentral":["5121"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for chronic kidney disease and has 1 investigational indication."}
{"id":"CHEMBL30816","canonicalSmiles":"CC(C)NCC(O)c1ccc(Cl)c(Cl)c1","inchiKey":"VKMGSWIFEHZQRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROISOPROTERENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Dichloroisoprenaline"],"drugbank":["DB12803"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31344","canonicalSmiles":"O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12","inchiKey":"KNBSYZNKEAWABY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL31344","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04175"]},"childChemblIds":["CHEMBL169776","CHEMBL3264006"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182621","canonicalSmiles":"Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O","inchiKey":"RWEVIPRMPFNTLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-424704","ARRY-704","AZD-8330","Azd 8330","Azd-8330","Azd8330"],"crossReferences":{"PubChem":["174006482"],"drugbank":["DB06061"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL31891","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1Br","inchiKey":"BFCRRLMMHNLSCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRODIMOPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brodimoprim"],"crossReferences":{"Wikipedia":["Brodimoprim"],"drugbank":["DB13795"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3260505","canonicalSmiles":"CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1","inchiKey":"NFTMKHWBOINJGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MBX-2982","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mbx-2982"],"crossReferences":{"drugbank":["DB12345"]},"linkedTargets":{"rows":["ENSG00000147262"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL329123","canonicalSmiles":"CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O","inchiKey":"YFIZRWPXUYFCSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETALOCIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etalocib","LY-193111","LY-293111","LY293111","Ly-293111","Ly293111","VML 295"],"crossReferences":{"Wikipedia":["Etalocib"],"drugbank":["DB12850"]},"linkedTargets":{"rows":["ENSG00000132170","ENSG00000213903"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3526802","canonicalSmiles":"O=C(CBr)N1CC([N+](=O)[O-])([N+](=O)[O-])C1","inchiKey":"JODKFOVZURLVTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RRX-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abdnaz","Radiosensitizer rrx-001","Rrx 001","Rrx-001"],"crossReferences":{"drugbank":["DB12060"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3544943","canonicalSmiles":"Cl.O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"UNDKJUKLBNARIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-863233","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3544944","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-863233","XL-413"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["MONDO_0004111","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545181","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21.O.[Br-]","inchiKey":"MQLXPRBEAHBZTK-SEINRUQRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOTROPIUM BROMIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1900528","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spiriva","Spiriva respimat"],"synonyms":["BA 679 BR","BA-679 BR","BA-679-BR","BA-679BR","Tiotropium bromide","Tiotropium bromide anhydrous","Tiotropium bromide hydrate","Tiotropium bromide monohydrate"],"crossReferences":{"DailyMed":["tiotropium%20bromide"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","HP_0000083","HP_0006536","EFO_0000464","EFO_0006505","EFO_1001919","MONDO_0004979","Orphanet_586","EFO_0000341","HP_0025428","MONDO_0004784"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 6 approved and 4 investigational indications."}
{"id":"CHEMBL3545247","drugType":"Small molecule","blackBoxWarning":false,"name":"CAL-263","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cal-263"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0005854"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545291","canonicalSmiles":"CN(C)C(=O)CCn1nc(Nc2ccc3c(c2)OC(F)(F)O3)nc1-c1ccncc1","inchiKey":"IURMHZBQEYNQOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-39393406","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-39393406"],"crossReferences":{"drugbank":["DB11867"]},"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004319","MONDO_0002050"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545384","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-85635","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sb-85635"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3559672","drugType":"Small molecule","blackBoxWarning":false,"name":"RAUWOLFIA SERPENTINA","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hiwolfia","Hyserpin","Koglucoid","Raudixin","Rauserpin","Rauval","Rauwolfia serpentina","Wolfina"],"synonyms":["Rauvolfia serpentina root","Rauwolfia alkaloids","Rauwolfia alkaloids, whole root","Rauwolfia serpentina","Rauwolfia serpentina alseroxylon","Rauwolfia serpentina root"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL361054","canonicalSmiles":"O=c1[nH]c(=O)n(CCCCN2CC=C(c3ccccc3)CC2)c2cccc(F)c12","inchiKey":"PNPFDRCIGCUCMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361054","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3785909","canonicalSmiles":"COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cnn(C)c5)cn34)c(=O)c2c1","inchiKey":"DWHXUGDWKAIASB-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3785909","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989922","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12.O","inchiKey":"ACNPUCQQZDAPJH-FMOMHUKBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIRAPARIB TOSYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1094636","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zejula"],"synonyms":["MK-4827-TOSYLATE","Niraparib tosylate","Niraparib tosylate monohydrate"],"crossReferences":{"DailyMed":["niraparib%20tosylate"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_0000304","EFO_0001075","EFO_0000564","EFO_1001100","EFO_1000251"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL400431","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2","inchiKey":"WPAPODFGOZXFLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405110","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.[Cl-]","inchiKey":"CXKWCBBOMKCUKX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTHIONINIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL191083","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206050","144212404","170465461","24811249"],"Wikipedia":["Methylene_blue","Rember"],"drugbank":["DB09241"],"chEBI":["6872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4084907","canonicalSmiles":"Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1","inchiKey":"ADGGYDAFIHSYFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMIRALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimiralisib","NC-B5","NCB5","PI3K-IN-2","PQR-309","PQR309","Pqr309"],"crossReferences":{"drugbank":["DB14846"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4094440","canonicalSmiles":"NS(=O)(=O)c1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1","inchiKey":"XGKULQQVQWCASY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-919373","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-919373"],"crossReferences":{"drugbank":["DB15047"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL410968","canonicalSmiles":"C=C(NC(=O)C(=C)NC(=O)c1csc(C2=NC3c4csc(n4)C4NC(=O)c5csc(n5)C(C(C)(O)C(C)O)NC(=O)C5CSC(=N5)/C(=C\\C)NC(=O)C(C(C)O)NC(=O)c5csc(n5)C3(CC2)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC2C=Cc3c(C(C)O)cc(nc3C2O)C(=O)OC4C)n1)C(N)=O","inchiKey":"NSFFHOGKXHRQEW-DVRIZHICSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CHEMBL410968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204055","26750027"],"drugbank":["DB11467"]},"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416230","canonicalSmiles":"CCCCCCCCCCOc1cc2c(O)c(C(=O)OCC)cnc2cc1OCC","inchiKey":"JHAYEQICABJSTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECOQUINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deccox","Decoquinate","HC 1528","HC-1528","M&B 15497","NSC-339057"],"crossReferences":{"PubChem":["144206276","170466244","50125820"],"Wikipedia":["Decoquinate"],"drugbank":["DB11394"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420910","canonicalSmiles":"CN(CCCC1CCCCC1)C(=O)[C@H](CCC(=O)O)NC(=O)N(CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1","inchiKey":"JSBQUMXQEBZYPW-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL420910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4227736","canonicalSmiles":"Cc1ccc(C(=O)Oc2ccc(C(CN(C)C)C3(O)CCCCC3)cc2)cc1","inchiKey":"QKYBZJLEMOZFFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLUDESVENLAFAXINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LPM-570065 FREE BASE","LPM570065 FREE BASE","LY-03005","LY03005","Ly03005","ODVP2","Toludesvenlafaxine"],"crossReferences":{"drugbank":["DB15052"]},"childChemblIds":["CHEMBL4650223"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL426926","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O","inchiKey":"MKKYBZZTJQGVCD-XTCKQBCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBEKACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbekacin","Arbekacin sulfate","ME-1100","ME1100"],"crossReferences":{"PubChem":["50112783"],"drugbank":["DB06696"],"chEBI":["37922"]},"childChemblIds":["CHEMBL3184482"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297166","drugType":"Unknown","blackBoxWarning":false,"name":"TEICOPLANIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Targocid"],"synonyms":["MDL 507","MDL-507","NSC-759183","Tagocid","Targosid","Teichomycin a2","Teicoplanin","Teicoplanin a2","Teikoplanin","Ticocin"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL4297203","canonicalSmiles":"O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"SVWHNLVZPGXBNS-RJUBDTSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUTOGLIPTIN TARTRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4296719","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dutogliptin tartrate","PHX-1149","PHX1149T","Phx1149t"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297273","canonicalSmiles":"Cl.N[C@H]1C[C@@H](C(=O)O)CC1=C(F)F","inchiKey":"PGVAKHBXGXBOSB-WINKWTMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPP-115","maximumClinicalTrialPhase":1,"parentId":"CHEMBL146927","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cpp-115"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297332","canonicalSmiles":"CCOCCCCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1C.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"DZRQMHSNVNTFAQ-IVGJVWKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UT-231B","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4300049","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ut-231b"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297343","canonicalSmiles":"CCCCCC=CCC=CCCCCCCC(O)C(=O)O","inchiKey":"AFDSETGKYZMEEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABTL-0812","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABTL0812","Abtl-0812","Abtl0812"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297397","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(OP(=O)(O)O)c2)oc2cc(O)cc(O)c12","inchiKey":"UWJBYNLLMAPJMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUERCETIN-3'-O-PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-quercetin phosphate","LIM-0705","Lim-0705","Quercetin 3'-phosphate","Quercetin-3'-o-phosphate"],"crossReferences":{"drugbank":["DB12937"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297548","drugType":"Unknown","blackBoxWarning":false,"name":"FIMASARTAN POTASSIUM TRIHYDRATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BR-A-657","Br-a-657","Fimasartan potassium trihydrate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297589","canonicalSmiles":"CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1","inchiKey":"FYXHWMQPCJOJCH-GMAHTHKFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELATOGREL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-246475","Act-246475","Selatogrel"],"crossReferences":{"drugbank":["DB15163"]},"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0001421","EFO_0008583"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297637","canonicalSmiles":"CC(=O)OC/C=C(C)/C=C/C=C(C)\\C=C\\C1=C(C)CCCC1(C)C","inchiKey":"QGNJRVVDBSJHIZ-AQDFTDIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZURETINOL ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-cis-retinal acetate","9-cis-retinyl acetate","9-cis-vitamin a acetate","9-cis-vitamin a1 acetate","QLT-091001","QLT091001","Qlt091001","Zuretinol acetate"],"crossReferences":{"drugbank":["DB12112"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297871","drugType":"Antibody","blackBoxWarning":false,"name":"CAMIDANLUMAB TESIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADCT-301","ADCT-301 TESIRINE","ADCT301","Adct 301","Adct 502","Adct-301 tesirine","Camidanlumab tesirine"],"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000220","EFO_0000222","EFO_0000183","EFO_0005952"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297952","drugType":"Unknown","blackBoxWarning":false,"name":"FB-825","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FB-825","FB825","Fb-825","Fb825"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297975","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT VARICELLA ZOSTER VIRUS (VZV) GLYCOPROTEIN E","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-1437173a","Herpes zoster vaccine gsk1437173a","Recombinant varicella zoster virus (vzv) glycoprotein e","Shingrix"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL43452","canonicalSmiles":"Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O","inchiKey":"UVSMNLNDYGZFPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"POMALIDOMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imnovid","Pomalyst"],"synonyms":["Actimid","CC-4047","IMID 3","IMID-3","Pomalidomide"],"crossReferences":{"DailyMed":["pomalidomide"],"PubChem":["174007398"],"Wikipedia":["Pomalidomide"],"drugbank":["DB08910"],"chEBI":["72690"]},"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["EFO_0003073","MONDO_0044903","EFO_0000558","Orphanet_232","EFO_0005952","EFO_0000540","Orphanet_85443","EFO_0002430","EFO_0004251","EFO_0004244","EFO_0000183","EFO_0000717","EFO_0009441","MONDO_0013730","EFO_0002618","EFO_0000616","EFO_0000403","EFO_0002939","EFO_1001968","EFO_0002429","MONDO_0008315","EFO_0009448","EFO_0006738","EFO_0006475","Orphanet_774","EFO_0000702","EFO_0001378","MONDO_0024880","MONDO_0015564","Orphanet_314701"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for multiple myeloma and immune system disease and has 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4475463","canonicalSmiles":"O=C(O)c1ccc2c(c1)CCCC(c1ccc(Cl)cc1Cl)=C2c1ccc(O[C@H]2CCN(CCCF)C2)cc1","inchiKey":"KISZAGQTIXIVAR-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMCENESTRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amcenestrant","SAR-439859","SAR439859","Sar439859"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0003968","EFO_0005537","MONDO_0007254"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL450449","canonicalSmiles":"COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4","inchiKey":"PKVRCIRHQMSYJX-AIFWHQITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRABECTEDIN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yondelis"],"synonyms":["ET-743","Ecteinascidin 743","Ecteinascidins trabectedin","NSC-648766","Trabectedin","Yondelis"],"crossReferences":{"DailyMed":["trabectedin"],"PubChem":["144206315","144206787"],"drugbank":["DB05109"],"chEBI":["84050"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 21 investigational indications."}
{"id":"CHEMBL4594331","drugType":"Protein","blackBoxWarning":false,"name":"DAZODALIBEP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dazodalibep","MEDI-4920","MEDI4920","Medi 4920","VIB-4920","VIB4920","Vib4920"],"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594504","drugType":"Unknown","blackBoxWarning":false,"name":"TCN-202","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCN-202","TCN202","Tcn-202"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650323","canonicalSmiles":"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1","inchiKey":"KOEUOFPEZFUWRF-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLEBRUTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tolebrutinib"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL47590","canonicalSmiles":"CNc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1","inchiKey":"OTMLAWRVLMYMDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL47590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483790","canonicalSmiles":"Nc1nc(-c2ccc(O)cc2)cs1","inchiKey":"QGSJYYIRAFRPIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07292"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490866","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CC[N+](CCCCCCCCN1C(=O)c3ccccc3C1=O)=C2","inchiKey":"VLGAHTYYCHWLNI-BHRZLAGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490866","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556937","canonicalSmiles":"O=C(O)CC(O)CC(=O)O","inchiKey":"ZQHYXNSQOIDNTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyglutarate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyglutarate"],"crossReferences":{"drugbank":["DB04594"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57","canonicalSmiles":"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1","inchiKey":"NQDJXKOVJZTUJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NEVIRAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nevirapine","Viramune","Viramune xr"],"synonyms":["BIRG 0587","BIRG-0587","NSC-641530","Nevirapine","Nevirapine anhydrous","Nevirapine teva","Nevirapine, anhydrous","Nevirapinum anhydrous","Viramune"],"crossReferences":{"DailyMed":["nevirapine"],"PubChem":["144207968","170464869","17388862","174006996","26719643","49718173","865943"],"Wikipedia":["Nevirapine"],"drugbank":["DB00238"],"chEBI":["63613"]},"childChemblIds":["CHEMBL4649102"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL577736","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O","inchiKey":"NLJVXZFCYKWXLH-DXTIXLATSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TYROTHRICIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactratycin"],"synonyms":["Tyrothricin"],"crossReferences":{"DrugCentral":["4739"]},"description":"Protein drug with a maximum clinical trial phase of IV and is indicated for eye infection."}
{"id":"CHEMBL605846","canonicalSmiles":"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1","inchiKey":"COUYJEVMBVSIHV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODATEROL","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Striverdi respimat"],"synonyms":["BI 1744","Olodaterol"],"crossReferences":{"DailyMed":["olodaterol%20hydrochloride"],"Wikipedia":["Olodaterol"],"drugbank":["DB09080"],"chEBI":["82700"]},"childChemblIds":["CHEMBL2105743"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000464","EFO_0001421","EFO_0006505","MONDO_0004979","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL64391","canonicalSmiles":"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O","inchiKey":"VHVPQPYKVGDNFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ITRACONAZOLE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Itraconazole","Onmel","Sporanos","Sporanox","Sporanox i.v.","Sporanox-pulse","Tolsura"],"synonyms":["Candistat","Canditral","Cladosal 100","Fungitraxx","Itrac","Itraconazole","Itralek","Itrazole","Itrizole","NSC-759239","Orungal","R 51,211","R-51211","Sempera","Spherazole cr","Spherazole ir","Sporamelt","Sporonox","Traconal","Triasporin"],"crossReferences":{"DailyMed":["itraconazole"],"PubChem":["104171385","174006588","26663153","26719680","29215099","56422506","855766"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 6 approved and 48 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL666","canonicalSmiles":"O=C(O)P(=O)(O)O","inchiKey":"ZJAOAACCNHFJAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSCARNET","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dihydroxyphosphinecarboxylic Acid Oxide","Foscarnet","J05AD01"],"crossReferences":{"DailyMed":["foscarnet%20sodium"],"Wikipedia":["Foscarnet"],"drugbank":["DB00529"],"chEBI":["127780"]},"childChemblIds":["CHEMBL754","CHEMBL4063154"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL686","canonicalSmiles":"Cc1cccc(Nc2ccccc2C(=O)O)c1C","inchiKey":"HYYBABOKPJLUIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEFENAMIC ACID","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Contraflam","Dysman-250","Dysman-500","Mefenamic acid","Meflam 250","Meflam 500","Mendys","Opustan 250","Opustan 500","Ponstan","Ponstan fte","Ponstel"],"synonyms":["CI-473","CN-35355","Gardan","INF-3355","J2.344B","M01AG01","Mefenamic acid","Mefenaminic acid","Mephenamic acid","Mephenaminic acid","NSC-94437"],"crossReferences":{"DailyMed":["mefenamic%20acid"],"PubChem":["104171280","11112163","124882006","144203895","144212300","170464813","26746974","26751493","56422190","855723"],"TG-GATEs":["84"],"Wikipedia":["Mefenamic_acid"],"drugbank":["DB00784"],"chEBI":["6717"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MP_0001914","HP_0100607","EFO_0000400","EFO_0003843","EFO_0005755","EFO_0009878"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for dysmenorrhea and rheumatic disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL77921","canonicalSmiles":"Cc1cccc(C(C)c2c[nH]cn2)c1C","inchiKey":"CUHVIMMYOGQXCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDETOMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Domitor"],"synonyms":["Medetomidine"],"crossReferences":{"Wikipedia":["Medetomidine"],"drugbank":["DB11428"],"chEBI":["48552"]},"childChemblIds":["CHEMBL537161"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL84617","canonicalSmiles":"CCC(=O)N(c1ccccc1F)C1(c2ccccc2)CCN(CCn2nnn(CC)c2=O)CC1","inchiKey":"RJSCINHYBGMIFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-3665","Trefentanil"],"crossReferences":{"Wikipedia":["Trefentanil"],"drugbank":["DB09181"]},"childChemblIds":["CHEMBL2107275"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL863","canonicalSmiles":"N[C@@H](CS)C(=O)O","inchiKey":"XUJNEKJLAYXESH-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cysteine","Cysteine HCl","Cysteinum","E 920","E920","E921","FEMA NO. 3263","L-cysteine","NSC-8746"],"crossReferences":{"DailyMed":["cysteine%20hydrochloride"],"drugbank":["DB00151"],"chEBI":["17561"]},"childChemblIds":["CHEMBL1200630"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for liver disease and has 3 investigational indications."}
{"id":"CHEMBL92636","canonicalSmiles":"Oc1cc2cc[nH]c2cc1O","inchiKey":"SGNZYJXNUURYCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92636","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01811"],"chEBI":["27404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94657","canonicalSmiles":"C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1","inchiKey":"QXRSDHAAWVKZLJ-PVYNADRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATUPILONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPO 906","EPO 906A","EPO-906","EPO-906A","Epithilone b","Epo b","Epothilone b","GNF-PF-193","Patupilone"],"crossReferences":{"PubChem":["50125842","520207"],"drugbank":["DB03010"],"chEBI":["31550"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000756","MONDO_0008170","MONDO_0007254","MONDO_0021063","EFO_0004243","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0003865","MONDO_0002158","EFO_1001100","EFO_0000182","EFO_0000673","MONDO_0024880","EFO_0000519","EFO_0004288"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL986","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1","inchiKey":"FPIPGXGPPPQFEQ-OVSJKPMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquasol a","Arovit","Nepalm","Retinol","Ro-a-vit","Vitamin A 1","Vitamin A Solubilized","Vitamin a"],"synonyms":["NSC-122759","Oleovitamin a","Retinol","Retinol (vit a)","Retinol acetate","Retinol palmitate","Vitamin A","Vitamin a","Vitamin a oil"],"crossReferences":{"PubChem":["104171352","124883068","144204369","144209639","144210607","17389530","26747393","26753109","26753110","416404","47193665","50105638"],"TG-GATEs":["59"],"Wikipedia":["Retinol","Vitamin_A"],"drugbank":["DB00162"],"chEBI":["17336"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 11 investigational indications."}
